Edition:
United States

Amphastar Pharmaceuticals Inc (AMPH.OQ)

AMPH.OQ on NASDAQ Stock Exchange Global Select Market

18.73USD
18 Oct 2018
Change (% chg)

$-0.14 (-0.74%)
Prev Close
$18.87
Open
$18.86
Day's High
$18.95
Day's Low
$18.67
Volume
41,091
Avg. Vol
71,791
52-wk High
$20.44
52-wk Low
$14.40

Chart for

About

Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company focuses primarily on developing, manufacturing, marketing and selling generic and injectable, inhalation and intranasal products. The Company has two segments: finished pharmaceutical products and active pharmaceutical ingredients (API) products.... (more)

Overall

Beta: 1.67
Market Cap(Mil.): $874.95
Shares Outstanding(Mil.): 46.20
Dividend: --
Yield (%): --

Financials

  AMPH.OQ Industry Sector
P/E (TTM): 232.59 30.91 33.65
EPS (TTM): 0.08 -- --
ROI: 1.11 14.75 14.28
ROE: 1.25 16.25 16.00

Amphastar cannot collect $100 mln during Momenta drug patent appeal - judge

A federal judge on Monday ruled that Amphastar Pharmaceuticals Inc must wait to collect a $100 million bond that Momenta Pharmaceuticals Inc and Sandoz Inc posted in a drug patent case it won until after an appellate court hears the dispute.

Jul 16 2018

BRIEF-Amphastar Pharmaceuticals Receives FDA Approval For Calcium Chloride Injection

* AMPHASTAR PHARMACEUTICALS RECEIVES FDA APPROVAL FOR CALCIUM CHLORIDE INJECTION

May 14 2018

Earnings vs. Estimates